Wordt geladen...
Bleeding Risk Following Percutaneous Coronary Intervention in Patients with Diabetes Prescribed Dual Anti-platelet Therapy
BACKGROUND: Patients with diabetes (DM) experience higher rates of in-stent restenosis and greater benefit from DES implant at the time of PCI, necessitating prolonged dual anti-platelet therapy (DAPT). While DAPT reduces risk of ischemic events post-PCI, it also increases risk of bleeding. Whether...
Bewaard in:
| Gepubliceerd in: | Am Heart J |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5357237/ https://ncbi.nlm.nih.gov/pubmed/27914490 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ahj.2016.09.010 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|